Chill out: cold cushion may take the sting out of nerve pain patch
NCT ID NCT02869867
First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This study tested whether using a refrigerated cushion during capsaicin patch application reduces the burning pain patients feel. One hundred adults with localized neuropathic pain were randomly assigned to get the patch with or without the cold cushion. The main goal was to see if the cold cushion lowered pain scores one hour after patch placement.
What this could mean
Our plain-language read of the trial. This is informational only, not medical advice or a prediction.
- Active substance
- refrigerated cushion
- What this could lead to
- If it works, this could offer a simple, drug-free way to make capsaicin patch treatment more comfortable for people with nerve pain.
- What could go wrong
- This is a small, completed study with no phase designation, so results may not be conclusive or widely applicable. The benefit may be modest or not meaningful for all patients.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Study facts
What this study's own registry entry says, in plain language.
- Phase
-
Not a phased trial
Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.
- Participants
-
100 people
The number who actually took part.
- Started
-
Mar 2017
- Finished
-
Dec 2020
- Lead sponsor
-
Other sponsor
The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.
Who can take part
This study's own entry requirements. Only the study team can say for certain whether you qualify.
- Ages
-
18 years and older
- Sex
-
Anyone
- Healthy volunteers
-
Not accepted
This study is not open to healthy volunteers. The entry requirements below say who it is open to.
Show the full entry requirements Hide the full entry requirements
Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.
Inclusion Criteria: * Major * Do not opposing the participation in the study * Monitoring in the case of localized neuropathic pain * Diagnostic with neuropathic pain score ≥ 4 * Neuropathic pain conventional treatment failure of first-line * Front advantage of laying a first patch Qutenza® * With ability to understand the proposed study Exclusion Criteria: * Patch Installation on the feet, face, mucous membranes * Eutectic mixture of local anesthetics (EMLA) Pose premedication * Having Already received prior to the installation of a patch of Qutenza® * Allergy to components Qutenza® * Known and poorly stabilized hypertension * Known cryoglobulinaemia * Pregnant or lactating women * Patient enjoying a measure of legal protection (guardianship, guardianship ...) * Private Patient freedom * No affiliation to a social security scheme. * Refusal to participate in the study
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for Localized neuropathic pain are added.
Genom att skicka in godkänner du våra Användarvillkor
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
CHD Vendée de la Roche sur Yon
La Roche-sur-Yon, 85925, France
-
CHLVO de Challans
Challans, 85300, France
-
Clinique Brétéché
Nantes, 44000, France